A Phase III, Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as Graft-Versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation
Phase of Trial: Phase III
Latest Information Update: 06 Dec 2016
At a glance
- Drugs Methotrexate (Primary) ; Sirolimus (Primary) ; Tacrolimus (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 06 Dec 2016 Results of biomarker study of endothelial damage and non-relapse mortality presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
- 08 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jun 2013 Planned end date changed from 1 Oct 2014 to 1 Oct 2015 as reported by ClinicalTrials.gov.